The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for moderate to severe acute pain. The drug, called Suzetrigine and manufactured by biotech ...
Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...
The unprecedented increase in drug overdose deaths in the U.S., long believed to be driven by access to legal and illegal ...